77 Ill. Adm. Code 697.20
Definitions
Section 697
Section 697.20Â Definitions
"Act"
means the AIDS Confidentiality Act.
"
AIDS"
means acquired immunodeficiency syndrome
(Section 3(a) of the Act).
"Blood
Bank" means any facility or location at which blood or plasma is procured,
furnished, donated, processed, stored or distributed.
"
Department"
means the Illinois Department of Public Health or its designated agents
.
(Section 3(f) of the Act)
"Designated
Agent" means an organization designated by the Department to conduct
public health activities in accordance with a written agreement with the Department.
"Director"
means the Director of the Illinois Department of Public Health.
"Health
Care Facility" or "Facility" means any institution, building or
agency, or portion of any institution, building or agency, whether public or
private (for-profit or nonprofit) that is used, operated or designed to provide
health services, medical treatment or nursing, rehabilitative or preventive
care to any person or persons, as well as
a hospital, nursing home, blood
bank, blood center, sperm bank, or other health care institution, including any
"health facility" as that term is defined in the Illinois Finance Authority
Act
[20 ILCS 3501] (Section 3(k) of the Act).
"Health
Care Professional"
means
any of the following:
a licensed
physician;
a physician
assistant to whom the physician assistant's supervising physician has delegated
the provision of AIDS and HIV-related health services;
an advanced
practice registered nurse who has a written collaborative agreement with a
collaborating physician which authorizes the provision of AIDS and HIV-related
health services;
an advance
practice nurse or physician assistant who practices in a hospital or ambulatory
surgical treatment center and possesses appropriate clinical privileges;
a licensed dentist;
a licensed podiatric physician; or
an individual
certified to provide HIV testing and counseling by a State or local public
health department.
(Section 3(i) of the Act)
"
Health
Care Provider"
has the meaning
ascribed by HIPAA as specified in 45
CFR 160.103
. (Section 3(j) of the Act)
"Health
Information Exchange" or "HIE" means a health information
exchange or health information organization that oversees and governs the
electronic exchange of health information that:
is
established pursuant to the Illinois Health Information Exchange and Technology
Act and any administrative rules adopted under that Act;
has
established a data sharing arrangement with the Authority; or
as of
August 16, 2013, was designated by the Authority Board as a member of, or was
represented on, the Authority Board's Regional Health Information Exchange
Workgroup;
provided
that designation shall not require the establishment of a data sharing
arrangement or other participation with the Illinois Health Information
Exchange or the payment of any fee. In certain circumstances, in accordance
with HIPAA, an HIE will be a business associate.
(Section 3(l) of the Act)
"HIPAA"
means the Health Insurance Portability and Accountability Act of 1996.
(Section 3(n) of the Act)
"HIV"
means the human immunodeficiency virus
. (Section 3(o) of the Act)
"HIV
Infection" means infected with HIV, as evidenced by a positive or reactive
supplemental laboratory test result.
"HIV-related
information" means the identity of a person upon whom an HIV test is
performed, the results of an HIV test, as well as diagnosis, treatment, and
prescription information that reveals a patient is HIV-positive, including
information contained in a limited data set. HIV-related information does not
include information that has been de-identified in accordance with HIPAA.
(Section 3(p) of the Act)
"
Informed
Consent" means:
when
a
health care provider, health care professional, or health facility has
implemented opt-in testing, a process by which an individual or
his or her
legal representative receives pre-test information, has an opportunity to ask
questions, and consents verbally or in writing to the test without undue
inducement or any element of force, fraud, deceit, duress, or other form of
constraint or coercion; or
when
a
health care provider, health care professional, or health care facility has
implemented opt-out testing, the individual or
his or her
legal
representative has been notified verbally or in writing that the test is
planned, has received pre-test information, has been given the opportunity to
ask questions and the opportunity to decline testing, and has not declined
testing.
(Section 3(q) of the Act)
"Laboratory"
means a CLIA approved or licensed facility at which tests are performed to
determine the presence of a sexually transmitted infection (STI).
"Legally
Authorized Representative" means an individual who is authorized to
consent to HIV testing and/or disclosure of HIV test results and HIV-related
information for an individual who is:
Under the age
of 12;
Deceased;
Declared
incompetent by a court of law; or
Otherwise not
competent to consent (for reasons other than age, such as the apparent
inability to understand or communicate with the health care professional) as
determined by the health care professional seeking the consent.
The following
individuals shall be authorized to consent, in the stated order of priority:
For a living or deceased child under the age of 18:
Parent, except
as limited by Section 9(k) of the Act providing limitations on the ability of
a parent or legal guardian to receive the child's test results, and Sections 4
and 5 of the Consent by Minors to Medical Procedures Act regarding release of
test results involving a sexually transmitted infection;
Legal guardian
or other court-appointed personal representative;
Adult
next-of-kin.
For a living or deceased adult age 18 or over:
Agent
authorized by durable power of attorney for health care;
Legal guardian
or other court-appointed personal representative;
Spouse;
Person in a
civil union;
Adult children;
Parent;
Adult
next-of-kin.
"Local
Health Authority" means
the full-time official health department or
board of health
recognized by the Department as
having jurisdiction over
a particular area
. (Section 3(2) of the Illinois Sexually Transmissible
Disease Control Act)
"Opt-in
testing" means an approach
in which
an HIV test is presented by
offering the test and the patient accepts or declines testing.
(Section
3(s-1) of the Act)
"Opt-out
testing" means an approach
in which
an HIV test is presented such
that a patient is notified that HIV testing may occur unless the patient
declines.
(Section 3(s-2) of the Act)
"Physician"
means a physician licensed to practice medicine under the Medical Practice Act
of 1987.
"Pre-test
information" means:
a reasonable
explanation of the test, including its purpose, potential uses, limitation, and
the meaning of its results; and
a
reasonable explanation of the procedures to be followed, including the
voluntary nature of the test, the availability of a qualified person to answer
questions, the right to withdraw consent to the testing process at any time,
the right to anonymity to the extent provided by law with respect to
participation in the test and disclosure of test results, and the right to
confidential treatment of information identifying the subject of the test and
the results of the test, to the extent provided by law
. (Section 3(w-5) of
the Act)
"Rapid
HIV Test" means any test approved by the U.S. Food and Drug Administration
(FDA) or validated under a laboratory's CLIA certification for the detection of
HIV that can be collected and processed within 60 minutes.
"Screening
Test" means any HIV test approved by the FDA or validated under a
laboratory's CLIA certification that must be followed by a supplemental test to
confirm a positive result.
"Sexually Transmissible Infection"
or "STI" means infection with syphilis, gonorrhea, chlamydia,
chancroid or HIV.
"Supplemental
Test" means any HIV test approved by the FDA or validated under a
laboratory's CLIA certification used to confirm the positive result of a screening
test.
"Test" or "HIV
Test" means a test to determine the presence of the antibody or antigen to
HIV, or of HIV infection
approved by the FDA or validated under a
laboratory's CLIA certification. (Section 3(aa) of the Act)
"Treatment" means the
provision, coordination or management of health care and related services by
one or more health care providers, including the coordination or management of
health care by a health care provider with a third party; consultation between
health care providers relating to a patient; or the referral of a patient for
health care from one health care provider to another. Treatment includes services
for prevention, diagnosis and medical management of STIs, including
examination, laboratory testing, medication and immunization.